MBX Capital is a venture capital firm specializing in early-stage investments in deep health startups at the intersection of biology, chemistry, AI/ML, robotics, and clinical medicine. Based in New York, the firm backs founders developing breakthrough solutions across drug discovery, diagnostics, therapeutics, and healthcare technologies that aim to transform patient care. The portfolio highlights collaborations across AI-driven drug formulation, IV infusion infrastructure, regenerative medicine, and safety/toxicology platforms, reflecting a focus on enabling advanced healthcare innovation globally.